SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maulcoin

Maulcoin is capturing market attention as the community rallies around its organic, meme-driven growth and a rejection of traditional, high-pressure marketing tactics. Investors are actively discussing the project's grassroots origins and the upcoming milestones intended to drive momentum and long-term engagement.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESH Acquisition Corp is experiencing significant investor interest driven by its status as a low-float SPAC, leading to high volatility and multiple trading halts. The community is actively debating the potential for a massive price squeeze, with many users drawing parallels to other recent high-momentum SPAC runs while debating the sustainability of the current price action.

Alexandria Real Estate Equities, Inc. engages in the provision of space for lease. It offers properties for rent to life science, agriculture technology (agtech), and technology tenants. The company was founded by Alan D. Gold, Gary A. Kreitzer, Joel S. Marcus, and Jerry M. Sudarsky in October 1994 and is headquartered in Pasadena, CA.

Alexandria Real Estate Equities Inc.

Alexandria Real Estate Equities (ARE) is currently drawing significant attention from investors who view the stock as deeply undervalued due to its historically low price-to-FFO ratios and substantial discounts to net asset value despite owning premium life science assets. While the broader market sentiment remains cautious regarding high interest rates and biotech sector headwinds, the community is actively debating whether current levels represent a generational buying opportunity or a deeper long-term correction.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as investors highlight its "phygital" brand strategy, specifically citing its massive retail presence in major chains and the launch of the Pengu Visa Card as key drivers for long-term utility. The community is actively discussing accumulation opportunities and comparing the project's unique revenue-generating model against traditional meme coins during this market phase.

Verizon Communications, Inc. is a holding company, which engages in the provision of communications, information, and entertainment products and services. It operates through the Consumer and Business segments. The Consumer segment provides consumer-focused wireless and wire line communications services and products. The Business segment offers wireless and wireline communications services and products, including FWA broadband, data, video and conferencing services, corporate networking solutions, security and managed network services, local and long-distance voice services, and network access to deliver various IoT services and products. The company was founded in 1983 and is headquartered in New York, NY.

Verizon Communications Inc

Verizon Communications Inc.

Verizon is seeing a massive surge in investor interest following strong earnings that highlighted record subscriber growth and a new multi-billion dollar share repurchase program. The community is sharply divided, with bulls pointing to the company's dividend reliability and successful strategic turnaround under new leadership, while bears remain skeptical, citing heavy debt loads and concerns over subscriber reporting metrics.

Shell Plc engages in the business of producing oil and natural gas. It operates through the following segments: Integrated Gas, Upstream, Marketing, Chemicals and Products, Renewables and Energy Solutions, and Corporate. The Integrated Gas segment includes liquefied natural gas, and conversion of natural gas into gas-to-liquids fuels. The Upstream segment focuses on exploration and extraction of crude oil, natural gas, and natural gas liquids. The Marketing segment is involved in mobility, lubricants, and sectors and decarbonization businesses. The Chemicals and Products segment consists of chemicals manufacturing plants with marketing network and refineries, which turn crude oil and other feedstocks into a range of oil products. The Renewables and Energy Solutions segment provides renewable power generation, marketing, trading, and optimizing power and pipeline gas, as well as carbon credits and digitally enabled customer solutions. The Corporate segment covers non-operating activities supporting Shell such as holdings, treasury organization, self-insurance activities, and headquarters and central functions. The company was founded in February 1907 and is headquartered in London, the United Kingdom.

Shell Plc - ADR (Representing - Ordinary Shares)

Shell is currently in the spotlight after the Dutch Court of Appeal overturned a landmark 2021 ruling that previously mandated the company to sharply reduce its carbon emissions. While investors and market participants are parsing the implications of this legal win on Shell's climate strategy and capital allocation, the stock continues to be influenced by broader energy sector volatility and the firm's ongoing efforts to balance transition goals with core fossil fuel profitability.

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ and GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Ideaya Biosciences Inc

Ideaya Biosciences is trending as investors focus on the upcoming April 13, 2026, topline Phase 2/3 data readout for its lead program, Darovasertib, in metastatic uveal melanoma. Community sentiment is high, with active discussions centered on the potential for an accelerated approval filing and the company's strong cash position, while institutional options activity suggests significant anticipation for a major price move.

NXP Semiconductors NV is a holding company which engages in the provision of semiconductor solutions. It operates through the following geographical segments: China, Netherlands, United States, Singapore, Germany, Japan, South Korea, Malaysia, and Other Countries. The company was founded on August 2, 2006, and is headquartered in Eindhoven, the Netherlands.

NXP Semiconductors NV

NXP Semiconductors is currently at the center of market volatility as investors weigh the impact of potential new U.S. export controls on Chinese chip manufacturing against the company's long-term growth prospects in the automotive and AI sectors. The community is actively debating whether the stock represents an oversold value opportunity or a risky play amid broader semiconductor sector uncertainty and shifting geopolitical trade regulations.

Royal Caribbean Group is a cruise company, which engages in the ownership and operation of the following global cruise brands: Royal Caribbean International, Celebrity Cruises, and Silversea Cruises. The firm also holds interest in TUI Cruises GmbH, which operates the German brands TUI Cruises and Hapag-Lloyd Cruises. The company was founded by Arne Wilhelmsen in 1968 and is headquartered in Miami, FL.

Royal Caribbean Group

Royal Caribbean is experiencing significant volatility as investors weigh strong booking demand and raised annual guidance against a quarterly revenue miss and concerns regarding the impact of weather-related disruptions. The broader cruise sector is facing downward pressure as the community actively debates whether the recent sell-off represents an overreaction to temporary operational hurdles or a signal of cooling consumer sentiment.

Aon Plc engages in the provision of risk, health, and wealth solutions. It focuses on risk capital including claim management, reinsurance, risk analysis, management, retention, and transfer; and human capital involving analytics, health and benefits, investments, pensions and retirement, talent and rewards, and workplace wellbeing. The company was founded in 1982 and is headquartered in Dublin, Ireland.

Aon plc. - Ordinary Shares - Class A

Aon is trending following mixed Q4 earnings results that showcased organic revenue growth and strong operational execution, alongside ongoing discussions about its strategic capital allocation and reinsurance partnerships. Investors are actively debating the company's long-term valuation and resilience in the face of complex macroeconomic pressures and insurance sector volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Selling: Apogee Therapeutics (NASDAQ:APGE) CEO Sells 20,000 Shares of Stock

Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) CEO Michael Thomas Henderson sold 20,000 shares of the firm's stock in a transaction on Wednesday, April 8th. The shares were sold at an average price of $82.58, for a total transaction of $1,651,600.00. Following the completion of the...

Aberdeen Group plc Lowers Stake in Apogee Therapeutics Inc. $APGE

Aberdeen Group plc lessened its stake in Apogee Therapeutics Inc. (NASDAQ:APGE - Free Report) by 34.1% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional...

Apogee Therapeutics (NASDAQ:APGE) Hits New 12-Month High - Still a Buy?

Apogee Therapeutics (NASDAQ:APGE) Reaches New 12-Month High - Should You Buy...

Apogee Therapeutics (NASDAQ:APGE) Insider Sells $466,620.00 in Stock

Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) insider Carl Dambkowski sold 5,500 shares of the firm's stock in a transaction dated Wednesday, April 1st. The shares were sold at an average...

Insider Selling: Apogee Therapeutics (NASDAQ:APGE) Insider Sells 5,500 Shares of Stock

Apogee Therapeutics Inc. (NASDAQ:APGE - Get Free Report) insider Carl Dambkowski sold 5,500 shares of the firm's stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $84.84, for a total transaction of $466,620.00. Following the transaction, the insider directly...

Banque Pictet & Cie SA Invests $3.16 Million in Apogee Therapeutics Inc. $APGE

Banque Pictet & Cie SA purchased a new position in Apogee Therapeutics Inc. (NASDAQ:APGE - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the...

SG Americas Securities LLC Sells 60,964 Shares of Apogee Therapeutics Inc. $APGE

SG Americas Securities LLC cut its stake in shares of Apogee Therapeutics Inc. (NASDAQ:APGE - Free Report) by 45.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 73,262 shares of the company's stock after selling 60,96...

Apogee Therapeutics (NASDAQ:APGE) Sets New 52-Week High - Here's What Happened

Apogee Therapeutics (NASDAQ:APGE) Sets New 1-Year High - Here's What Happened...

Apogee Therapeutics (NASDAQ:APGE) Price Target Raised to $110.00 at Mizuho

Mizuho upped their price target on shares of Apogee Therapeutics from $105.00 to $110.00 and gave the company an "outperform" rating in a research report on Monday...

Apogee Therapeutics (NASDAQ:APGE) Reaches New 52-Week High - Here's Why

Apogee Therapeutics (NASDAQ:APGE) Hits New 12-Month High - Here's What Happened...

Apogee Therapeutics, Inc. is a clinical stage biotechnology company. It offers treatment of atopic dermatitis (AD), ashma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded by Andrew Gottesdiener and Nimish P. Shah in 2022 and is headquartered in Waltham, MA.

Current Price	$86.27
Prev Close	$86.52
Open	$86.53
Dividend Yield	0.00%
50-Day Moving Average	$72.56
Beta	0.00
Avg. Volume	1.31M
PE Ratio	-20.47

52-Week High	$88.35
52-Week Low	$31.21
Market Capitalization	$5.99B
EPS (Annual)	-$4.22
Price to Book	6.53
Revenue Per Employee	$0.00

APGE
Apogee Therapeutics

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest APGE News

APGEApogee Therapeutics